FOSRENOL: Focused on the Challenging Needs of Patients With ESRD

FOSRENOL Chewable Tablets:

  • Provided effective phosphate reduction in studies lasting up to 3 years2-4
  • Over 5200 patients studied in completed clinical trials1

NEW FOSRENOL Oral Powder:

  • A phosphate binder specifically formulated to be mixed with applesauce or other similar food and not liquid1
  • Same active ingredient as FOSRENOL Chewable Tablets1

FOSRENOL On Track™ Support Program:

  • Reinforces your efforts with materials that may help patients manage their condition

Learn More

Dosing Options

Send to a Colleague

X

No personal information (including e-mail addresses) will be collected from this feature.